| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Graves Ophthalmopathy | 21 | 2023 | 117 | 10.080 |
Why?
|
| Orbital Neoplasms | 20 | 2023 | 225 | 6.200 |
Why?
|
| Eyelids | 18 | 2023 | 263 | 5.340 |
Why?
|
| Orbit | 21 | 2023 | 427 | 4.920 |
Why?
|
| Orbital Diseases | 12 | 2022 | 181 | 4.400 |
Why?
|
| Eyelid Diseases | 14 | 2022 | 155 | 4.310 |
Why?
|
| Eyelid Neoplasms | 9 | 2022 | 94 | 3.360 |
Why?
|
| Oculomotor Muscles | 7 | 2023 | 371 | 2.920 |
Why?
|
| Ophthalmologic Surgical Procedures | 11 | 2021 | 349 | 2.750 |
Why?
|
| Dacryocystorhinostomy | 9 | 2018 | 72 | 2.680 |
Why?
|
| Conjunctival Neoplasms | 6 | 2020 | 79 | 2.560 |
Why?
|
| Exophthalmos | 5 | 2023 | 96 | 2.480 |
Why?
|
| Nasolacrimal Duct | 10 | 2018 | 74 | 2.470 |
Why?
|
| Lacrimal Apparatus | 7 | 2022 | 224 | 2.230 |
Why?
|
| Conjunctiva | 8 | 2022 | 493 | 2.220 |
Why?
|
| Blepharoplasty | 6 | 2023 | 50 | 1.910 |
Why?
|
| Endoscopy | 18 | 2023 | 1774 | 1.870 |
Why?
|
| Ectropion | 4 | 2020 | 26 | 1.840 |
Why?
|
| Optic Nerve Diseases | 5 | 2021 | 327 | 1.830 |
Why?
|
| Orbital Pseudotumor | 4 | 2016 | 42 | 1.720 |
Why?
|
| Orbital Implants | 4 | 2021 | 21 | 1.580 |
Why?
|
| Blepharoptosis | 7 | 2021 | 144 | 1.540 |
Why?
|
| Ophthalmology | 13 | 2023 | 506 | 1.530 |
Why?
|
| Lacrimal Apparatus Diseases | 5 | 2019 | 65 | 1.480 |
Why?
|
| Eye Diseases | 3 | 2022 | 670 | 1.460 |
Why?
|
| Eye Infections, Bacterial | 4 | 2017 | 235 | 1.440 |
Why?
|
| Mucormycosis | 3 | 2022 | 97 | 1.430 |
Why?
|
| Pemphigoid, Benign Mucous Membrane | 3 | 2023 | 123 | 1.430 |
Why?
|
| Entropion | 3 | 2020 | 10 | 1.370 |
Why?
|
| Visual Fields | 5 | 2020 | 1049 | 1.370 |
Why?
|
| Orbital Fractures | 4 | 2020 | 110 | 1.320 |
Why?
|
| Lacrimal Duct Obstruction | 5 | 2016 | 48 | 1.270 |
Why?
|
| Intubation | 3 | 2019 | 141 | 1.190 |
Why?
|
| Orbital Cellulitis | 4 | 2015 | 33 | 1.180 |
Why?
|
| Dacryocystitis | 3 | 2017 | 69 | 1.090 |
Why?
|
| Eyebrows | 2 | 2017 | 29 | 1.040 |
Why?
|
| Neurilemmoma | 3 | 2020 | 547 | 1.030 |
Why?
|
| Decompression, Surgical | 6 | 2023 | 593 | 1.010 |
Why?
|
| Hemangioma, Cavernous | 4 | 2023 | 110 | 1.000 |
Why?
|
| Eye Neoplasms | 3 | 2019 | 313 | 0.990 |
Why?
|
| Sphenoid Bone | 4 | 2021 | 172 | 0.910 |
Why?
|
| Sentinel Lymph Node Biopsy | 2 | 2020 | 701 | 0.900 |
Why?
|
| Nasal Cavity | 3 | 2016 | 312 | 0.890 |
Why?
|
| Mucorales | 2 | 2022 | 33 | 0.890 |
Why?
|
| Diplopia | 6 | 2023 | 199 | 0.870 |
Why?
|
| Vision Disorders | 3 | 2019 | 1057 | 0.860 |
Why?
|
| Corneal Diseases | 3 | 2019 | 615 | 0.860 |
Why?
|
| Anophthalmos | 2 | 2021 | 22 | 0.830 |
Why?
|
| Vascular Malformations | 2 | 2020 | 450 | 0.810 |
Why?
|
| Minocycline | 1 | 2022 | 163 | 0.800 |
Why?
|
| Keratoacanthoma | 1 | 2021 | 32 | 0.790 |
Why?
|
| Hyperpigmentation | 1 | 2022 | 112 | 0.780 |
Why?
|
| Suture Techniques | 3 | 2014 | 797 | 0.750 |
Why?
|
| Tomography, X-Ray Computed | 24 | 2021 | 20086 | 0.700 |
Why?
|
| Imidazoles | 2 | 2017 | 1205 | 0.700 |
Why?
|
| Ophthalmic Nerve | 1 | 2019 | 43 | 0.690 |
Why?
|
| Cysts | 4 | 2018 | 676 | 0.690 |
Why?
|
| Lymphoma, Extranodal NK-T-Cell | 1 | 2019 | 44 | 0.680 |
Why?
|
| Humans | 149 | 2024 | 742088 | 0.680 |
Why?
|
| Biopsy | 11 | 2020 | 6756 | 0.650 |
Why?
|
| Lymphatic Abnormalities | 1 | 2020 | 133 | 0.650 |
Why?
|
| Technology Assessment, Biomedical | 5 | 2021 | 307 | 0.650 |
Why?
|
| Eye Injuries | 4 | 2019 | 245 | 0.640 |
Why?
|
| Factor XIIIa | 1 | 2017 | 10 | 0.630 |
Why?
|
| Horner Syndrome | 1 | 2018 | 37 | 0.630 |
Why?
|
| Eye Infections, Fungal | 2 | 2016 | 110 | 0.630 |
Why?
|
| Eye, Artificial | 1 | 2017 | 18 | 0.630 |
Why?
|
| Lymphoma, B-Cell, Marginal Zone | 2 | 2018 | 180 | 0.620 |
Why?
|
| Blepharophimosis | 1 | 2017 | 22 | 0.620 |
Why?
|
| Sarcoma, Myeloid | 1 | 2018 | 59 | 0.610 |
Why?
|
| Nerve Transfer | 1 | 2019 | 120 | 0.610 |
Why?
|
| Nevus | 1 | 2019 | 204 | 0.610 |
Why?
|
| Dermoid Cyst | 1 | 2018 | 92 | 0.610 |
Why?
|
| Ectodermal Dysplasia | 1 | 2018 | 103 | 0.610 |
Why?
|
| Eye Hemorrhage | 1 | 2017 | 19 | 0.600 |
Why?
|
| Retinal Vein Occlusion | 1 | 2018 | 137 | 0.600 |
Why?
|
| Cranial Nerve Diseases | 1 | 2017 | 112 | 0.590 |
Why?
|
| Skull Neoplasms | 1 | 2018 | 173 | 0.590 |
Why?
|
| Histiocytoma, Benign Fibrous | 1 | 2017 | 109 | 0.590 |
Why?
|
| Retrospective Studies | 48 | 2023 | 77098 | 0.580 |
Why?
|
| Orbit Evisceration | 1 | 2016 | 8 | 0.580 |
Why?
|
| Pyoderma Gangrenosum | 1 | 2017 | 75 | 0.570 |
Why?
|
| Cicatrix | 3 | 2019 | 761 | 0.570 |
Why?
|
| Choroid | 1 | 2018 | 317 | 0.570 |
Why?
|
| Port-Wine Stain | 1 | 2016 | 33 | 0.570 |
Why?
|
| Fasciitis, Necrotizing | 1 | 2017 | 79 | 0.570 |
Why?
|
| Tomography, Optical Coherence | 3 | 2019 | 2637 | 0.570 |
Why?
|
| Eye Foreign Bodies | 1 | 2017 | 55 | 0.560 |
Why?
|
| Dermis | 1 | 2017 | 207 | 0.550 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2017 | 293 | 0.550 |
Why?
|
| Maxillary Sinus | 2 | 2014 | 180 | 0.550 |
Why?
|
| Surgical Sponges | 1 | 2016 | 46 | 0.550 |
Why?
|
| Debridement | 3 | 2017 | 492 | 0.550 |
Why?
|
| Sphenoid Sinus | 2 | 2018 | 100 | 0.540 |
Why?
|
| Oximes | 1 | 2017 | 309 | 0.540 |
Why?
|
| Erythema | 1 | 2017 | 254 | 0.540 |
Why?
|
| Middle Aged | 63 | 2023 | 213127 | 0.530 |
Why?
|
| Nerve Compression Syndromes | 1 | 2017 | 161 | 0.530 |
Why?
|
| Antigens, CD34 | 1 | 2017 | 657 | 0.530 |
Why?
|
| Mydriatics | 1 | 2015 | 68 | 0.520 |
Why?
|
| Ethmoid Sinus | 1 | 2015 | 58 | 0.520 |
Why?
|
| Sutures | 2 | 2014 | 298 | 0.520 |
Why?
|
| Academies and Institutes | 7 | 2023 | 317 | 0.520 |
Why?
|
| Oculomotor Nerve | 2 | 2019 | 74 | 0.520 |
Why?
|
| Paranasal Sinus Diseases | 2 | 2021 | 116 | 0.510 |
Why?
|
| Pyrimidinones | 1 | 2017 | 370 | 0.510 |
Why?
|
| Glucocorticoids | 6 | 2022 | 2107 | 0.510 |
Why?
|
| Male | 76 | 2023 | 349538 | 0.510 |
Why?
|
| Fluorescein Angiography | 2 | 2018 | 936 | 0.500 |
Why?
|
| Prosthesis Implantation | 3 | 2021 | 641 | 0.500 |
Why?
|
| Phenylephrine | 1 | 2015 | 301 | 0.500 |
Why?
|
| Contact Lenses | 1 | 2016 | 145 | 0.500 |
Why?
|
| Rhabdomyosarcoma | 1 | 2017 | 382 | 0.490 |
Why?
|
| Hernia | 1 | 2014 | 71 | 0.490 |
Why?
|
| Skin Aging | 1 | 2015 | 127 | 0.490 |
Why?
|
| Alopecia | 1 | 2018 | 381 | 0.480 |
Why?
|
| Skin Transplantation | 2 | 2019 | 1074 | 0.480 |
Why?
|
| Eyelashes | 1 | 2014 | 17 | 0.480 |
Why?
|
| Skin Neoplasms | 4 | 2019 | 5662 | 0.480 |
Why?
|
| Myxoma | 1 | 2014 | 130 | 0.470 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2018 | 600 | 0.470 |
Why?
|
| Eye Infections, Viral | 1 | 2014 | 57 | 0.470 |
Why?
|
| Ophthalmic Artery | 1 | 2014 | 60 | 0.470 |
Why?
|
| Panophthalmitis | 1 | 2013 | 6 | 0.460 |
Why?
|
| Edema | 2 | 2017 | 790 | 0.460 |
Why?
|
| Nerve Regeneration | 1 | 2019 | 791 | 0.460 |
Why?
|
| Hyperglycemia | 1 | 2022 | 1368 | 0.460 |
Why?
|
| Facial Paralysis | 1 | 2017 | 338 | 0.460 |
Why?
|
| Chalazion | 1 | 2013 | 13 | 0.460 |
Why?
|
| Melanoma | 3 | 2017 | 5462 | 0.450 |
Why?
|
| Alendronate | 1 | 2014 | 171 | 0.450 |
Why?
|
| Female | 74 | 2023 | 379592 | 0.440 |
Why?
|
| Streptococcal Infections | 1 | 2017 | 637 | 0.430 |
Why?
|
| Rhabdoid Tumor | 1 | 2014 | 212 | 0.430 |
Why?
|
| Pyridones | 1 | 2017 | 712 | 0.430 |
Why?
|
| Keratins | 2 | 2016 | 515 | 0.430 |
Why?
|
| Aged, 80 and over | 23 | 2023 | 57683 | 0.430 |
Why?
|
| Lymphatic Metastasis | 1 | 2020 | 2906 | 0.420 |
Why?
|
| Terminology as Topic | 1 | 2019 | 1548 | 0.420 |
Why?
|
| Carcinoma | 2 | 2015 | 2374 | 0.420 |
Why?
|
| Fever | 3 | 2021 | 1612 | 0.420 |
Why?
|
| Emphysema | 1 | 2015 | 247 | 0.410 |
Why?
|
| Aged | 44 | 2023 | 162944 | 0.410 |
Why?
|
| Cornea | 2 | 2019 | 1497 | 0.410 |
Why?
|
| Surgical Flaps | 6 | 2022 | 1634 | 0.400 |
Why?
|
| Keratosis, Actinic | 1 | 2012 | 74 | 0.400 |
Why?
|
| Frail Elderly | 1 | 2016 | 691 | 0.390 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2017 | 687 | 0.380 |
Why?
|
| Nose | 3 | 2023 | 509 | 0.360 |
Why?
|
| Foreign Bodies | 1 | 2014 | 398 | 0.360 |
Why?
|
| Adipose Tissue | 3 | 2021 | 3278 | 0.360 |
Why?
|
| Neuroblastoma | 1 | 2018 | 1225 | 0.360 |
Why?
|
| Continuous Positive Airway Pressure | 1 | 2015 | 546 | 0.360 |
Why?
|
| Cocaine-Related Disorders | 1 | 2013 | 460 | 0.360 |
Why?
|
| Diphosphonates | 1 | 2014 | 625 | 0.350 |
Why?
|
| Immunohistochemistry | 6 | 2019 | 11363 | 0.350 |
Why?
|
| Escherichia coli Infections | 1 | 2013 | 532 | 0.340 |
Why?
|
| Football | 1 | 2014 | 460 | 0.340 |
Why?
|
| Herpesvirus 4, Human | 1 | 2014 | 1040 | 0.340 |
Why?
|
| Blindness | 1 | 2013 | 615 | 0.330 |
Why?
|
| Lymph Nodes | 1 | 2020 | 3465 | 0.330 |
Why?
|
| Carcinoma, Squamous Cell | 3 | 2021 | 4029 | 0.320 |
Why?
|
| Visual Field Tests | 3 | 2019 | 383 | 0.320 |
Why?
|
| Staphylococcal Infections | 1 | 2017 | 1398 | 0.320 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2019 | 1596 | 0.320 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2014 | 569 | 0.320 |
Why?
|
| Craniopharyngioma | 2 | 2001 | 281 | 0.310 |
Why?
|
| Receptors, Cell Surface | 1 | 2017 | 2867 | 0.310 |
Why?
|
| Cocaine | 1 | 2013 | 1008 | 0.310 |
Why?
|
| B-Lymphocytes | 3 | 2018 | 4664 | 0.310 |
Why?
|
| Retina | 1 | 2018 | 2611 | 0.300 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2017 | 2028 | 0.300 |
Why?
|
| Adult | 40 | 2023 | 213712 | 0.300 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2012 | 1107 | 0.300 |
Why?
|
| Eye Enucleation | 4 | 2021 | 128 | 0.290 |
Why?
|
| Dry Eye Syndromes | 2 | 2023 | 382 | 0.290 |
Why?
|
| Bone Density Conservation Agents | 1 | 2014 | 774 | 0.290 |
Why?
|
| Stents | 2 | 2019 | 3276 | 0.290 |
Why?
|
| Antigens, CD | 1 | 2017 | 4024 | 0.290 |
Why?
|
| Hypesthesia | 2 | 2019 | 110 | 0.290 |
Why?
|
| Anesthetics, Local | 1 | 2013 | 984 | 0.280 |
Why?
|
| Magnetic Resonance Imaging | 19 | 2019 | 35342 | 0.270 |
Why?
|
| Treatment Outcome | 19 | 2023 | 62966 | 0.270 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2014 | 2940 | 0.270 |
Why?
|
| Bone Neoplasms | 1 | 2018 | 2522 | 0.260 |
Why?
|
| Molecular Targeted Therapy | 2 | 2016 | 2723 | 0.260 |
Why?
|
| Ultrasonography | 1 | 2019 | 5978 | 0.260 |
Why?
|
| Surgery, Plastic | 1 | 2012 | 618 | 0.260 |
Why?
|
| Diagnosis, Differential | 9 | 2021 | 12958 | 0.260 |
Why?
|
| Skin Abnormalities | 2 | 2017 | 60 | 0.260 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2015 | 1377 | 0.260 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2014 | 1515 | 0.260 |
Why?
|
| Conjunctival Diseases | 2 | 2016 | 121 | 0.260 |
Why?
|
| Disease Management | 1 | 2016 | 2450 | 0.260 |
Why?
|
| Nasal Mucosa | 2 | 2018 | 373 | 0.250 |
Why?
|
| Paranasal Sinuses | 2 | 2017 | 249 | 0.240 |
Why?
|
| Quality Improvement | 1 | 2019 | 3738 | 0.230 |
Why?
|
| Follow-Up Studies | 12 | 2019 | 39004 | 0.220 |
Why?
|
| Epidermal Cyst | 2 | 2016 | 62 | 0.220 |
Why?
|
| Receptors, Thyrotropin | 1 | 2022 | 45 | 0.220 |
Why?
|
| Pituitary Neoplasms | 2 | 2001 | 1340 | 0.210 |
Why?
|
| Dioxygenases | 1 | 2024 | 316 | 0.210 |
Why?
|
| Materia Medica | 1 | 2021 | 12 | 0.200 |
Why?
|
| Postoperative Complications | 5 | 2021 | 15244 | 0.200 |
Why?
|
| Ecchymosis | 1 | 2021 | 32 | 0.200 |
Why?
|
| Otolaryngology | 2 | 2020 | 644 | 0.200 |
Why?
|
| Face | 3 | 2023 | 993 | 0.200 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2017 | 5522 | 0.190 |
Why?
|
| Salmonella enteritidis | 1 | 2000 | 17 | 0.190 |
Why?
|
| Oxazolone | 1 | 2020 | 60 | 0.190 |
Why?
|
| Systemic Vasculitis | 1 | 2020 | 37 | 0.190 |
Why?
|
| Antineoplastic Agents | 4 | 2019 | 13655 | 0.180 |
Why?
|
| Polyhydroxyethyl Methacrylate | 1 | 2019 | 31 | 0.180 |
Why?
|
| Giant Cell Arteritis | 1 | 2024 | 292 | 0.180 |
Why?
|
| Streptavidin | 1 | 1999 | 81 | 0.170 |
Why?
|
| Tears | 2 | 2020 | 252 | 0.170 |
Why?
|
| Optic Nerve Injuries | 1 | 2020 | 151 | 0.170 |
Why?
|
| Scleral Buckling | 1 | 2019 | 84 | 0.170 |
Why?
|
| Maxillary Fractures | 1 | 2019 | 20 | 0.170 |
Why?
|
| Prevalence | 1 | 2016 | 15194 | 0.170 |
Why?
|
| Zygomatic Fractures | 1 | 2019 | 37 | 0.170 |
Why?
|
| Sclerotherapy | 1 | 2020 | 175 | 0.170 |
Why?
|
| Vitamin K | 1 | 2021 | 294 | 0.170 |
Why?
|
| Rupture | 4 | 2014 | 430 | 0.170 |
Why?
|
| Food Contamination | 1 | 2000 | 189 | 0.170 |
Why?
|
| Strabismus | 1 | 2023 | 287 | 0.170 |
Why?
|
| Salmonella Infections | 1 | 2000 | 173 | 0.170 |
Why?
|
| Hemianopsia | 1 | 2000 | 122 | 0.160 |
Why?
|
| Alphapapillomavirus | 1 | 2021 | 221 | 0.160 |
Why?
|
| Biotin | 1 | 1999 | 253 | 0.160 |
Why?
|
| Facial Neoplasms | 1 | 2019 | 121 | 0.160 |
Why?
|
| Palate, Hard | 1 | 2018 | 57 | 0.160 |
Why?
|
| Germany | 2 | 2016 | 860 | 0.160 |
Why?
|
| Adolescent | 14 | 2023 | 85649 | 0.160 |
Why?
|
| Preoperative Period | 2 | 2017 | 546 | 0.160 |
Why?
|
| Penicillin G | 1 | 2017 | 42 | 0.150 |
Why?
|
| Plant Extracts | 1 | 2021 | 469 | 0.150 |
Why?
|
| Drug Therapy, Combination | 3 | 2017 | 6483 | 0.150 |
Why?
|
| Blinking | 2 | 2017 | 138 | 0.150 |
Why?
|
| Lacerations | 1 | 2019 | 144 | 0.150 |
Why?
|
| Sampling Studies | 1 | 2019 | 623 | 0.150 |
Why?
|
| Fundus Oculi | 1 | 2018 | 472 | 0.150 |
Why?
|
| Nuclear Medicine | 1 | 2020 | 233 | 0.150 |
Why?
|
| Combined Modality Therapy | 3 | 2017 | 8621 | 0.150 |
Why?
|
| Cadaver | 3 | 2019 | 1333 | 0.150 |
Why?
|
| Corneal Ulcer | 2 | 2017 | 169 | 0.150 |
Why?
|
| Visual Acuity | 6 | 2016 | 2520 | 0.150 |
Why?
|
| Submandibular Gland | 1 | 2017 | 86 | 0.150 |
Why?
|
| Streptococcus | 1 | 2017 | 197 | 0.140 |
Why?
|
| Cautery | 1 | 2017 | 72 | 0.140 |
Why?
|
| Optic Disk | 1 | 2020 | 401 | 0.140 |
Why?
|
| Exanthema | 1 | 2021 | 488 | 0.140 |
Why?
|
| Anti-Bacterial Agents | 4 | 2022 | 7153 | 0.140 |
Why?
|
| Neoplasm Recurrence, Local | 4 | 2020 | 9185 | 0.140 |
Why?
|
| Silicone Elastomers | 1 | 2016 | 84 | 0.140 |
Why?
|
| Pigmentation | 1 | 2016 | 148 | 0.140 |
Why?
|
| Panuveitis | 1 | 2016 | 32 | 0.140 |
Why?
|
| Infant | 7 | 2023 | 35070 | 0.140 |
Why?
|
| Eye Pain | 2 | 2013 | 47 | 0.140 |
Why?
|
| Carotid-Cavernous Sinus Fistula | 1 | 2016 | 40 | 0.140 |
Why?
|
| Melanosis | 1 | 2016 | 78 | 0.130 |
Why?
|
| Hospitals, Special | 1 | 2016 | 101 | 0.130 |
Why?
|
| Gels | 1 | 2017 | 427 | 0.130 |
Why?
|
| Models, Anatomic | 1 | 2019 | 690 | 0.130 |
Why?
|
| Immunoglobulin G | 3 | 2023 | 4554 | 0.130 |
Why?
|
| Hair Diseases | 1 | 2016 | 74 | 0.130 |
Why?
|
| Histiocytes | 1 | 2015 | 103 | 0.130 |
Why?
|
| Antibodies, Blocking | 1 | 2016 | 254 | 0.130 |
Why?
|
| Lymphangiogenesis | 1 | 2016 | 172 | 0.130 |
Why?
|
| Fusobacterium necrophorum | 1 | 2014 | 14 | 0.130 |
Why?
|
| Cavernous Sinus Thrombosis | 1 | 2014 | 14 | 0.130 |
Why?
|
| Silicones | 1 | 2016 | 248 | 0.130 |
Why?
|
| Frontal Lobe | 1 | 2001 | 1407 | 0.130 |
Why?
|
| Lemierre Syndrome | 1 | 2014 | 14 | 0.130 |
Why?
|
| Neovascularization, Pathologic | 2 | 2016 | 2633 | 0.130 |
Why?
|
| Consensus | 2 | 2020 | 2935 | 0.120 |
Why?
|
| Eye Injuries, Penetrating | 3 | 1994 | 115 | 0.120 |
Why?
|
| Antifungal Agents | 2 | 2016 | 729 | 0.120 |
Why?
|
| Societies, Medical | 2 | 2019 | 3740 | 0.120 |
Why?
|
| Retinal Cone Photoreceptor Cells | 1 | 2015 | 177 | 0.120 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2018 | 546 | 0.120 |
Why?
|
| Glass | 1 | 2014 | 113 | 0.120 |
Why?
|
| Lymph Node Excision | 1 | 2020 | 1248 | 0.120 |
Why?
|
| Young Adult | 7 | 2018 | 56350 | 0.120 |
Why?
|
| Quality of Life | 4 | 2022 | 12730 | 0.120 |
Why?
|
| Bioartificial Organs | 1 | 2014 | 49 | 0.120 |
Why?
|
| Remission, Spontaneous | 1 | 2014 | 380 | 0.120 |
Why?
|
| Hair Follicle | 1 | 2016 | 209 | 0.120 |
Why?
|
| Parotid Gland | 1 | 2014 | 168 | 0.120 |
Why?
|
| Documentation | 1 | 2020 | 865 | 0.120 |
Why?
|
| Massachusetts | 2 | 2017 | 8662 | 0.120 |
Why?
|
| Vancomycin | 1 | 2017 | 500 | 0.120 |
Why?
|
| False Negative Reactions | 1 | 2015 | 587 | 0.120 |
Why?
|
| Prostaglandins, Synthetic | 1 | 2013 | 21 | 0.120 |
Why?
|
| Leiomyosarcoma | 1 | 2017 | 477 | 0.110 |
Why?
|
| Communicable Diseases | 1 | 2022 | 878 | 0.110 |
Why?
|
| Aspergillosis | 1 | 2015 | 235 | 0.110 |
Why?
|
| Microscopy, Confocal | 1 | 2019 | 1969 | 0.110 |
Why?
|
| Eye Burns | 1 | 2014 | 102 | 0.110 |
Why?
|
| Viscosupplements | 1 | 2013 | 23 | 0.110 |
Why?
|
| Granuloma, Foreign-Body | 1 | 2013 | 45 | 0.110 |
Why?
|
| Burns, Chemical | 1 | 2014 | 154 | 0.110 |
Why?
|
| Sirolimus | 1 | 2020 | 1562 | 0.110 |
Why?
|
| Endoscopes | 1 | 2013 | 174 | 0.110 |
Why?
|
| Carcinoma, Lobular | 1 | 2017 | 484 | 0.110 |
Why?
|
| Rupture, Spontaneous | 1 | 2013 | 354 | 0.110 |
Why?
|
| Immunoenzyme Techniques | 1 | 2015 | 1799 | 0.110 |
Why?
|
| United States | 9 | 2021 | 69693 | 0.110 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2019 | 1183 | 0.100 |
Why?
|
| Azithromycin | 1 | 2013 | 195 | 0.100 |
Why?
|
| Administration, Intranasal | 1 | 2013 | 446 | 0.100 |
Why?
|
| Antibodies, Monoclonal | 2 | 2022 | 9274 | 0.100 |
Why?
|
| Adrenal Cortex Hormones | 2 | 2021 | 1847 | 0.100 |
Why?
|
| Ophthalmoplegia | 1 | 2013 | 166 | 0.100 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2017 | 4029 | 0.100 |
Why?
|
| Child | 8 | 2020 | 77478 | 0.100 |
Why?
|
| Nasopharyngeal Diseases | 1 | 2011 | 25 | 0.100 |
Why?
|
| Meningeal Neoplasms | 1 | 2020 | 1241 | 0.100 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 2014 | 659 | 0.100 |
Why?
|
| Uveitis | 1 | 2015 | 375 | 0.100 |
Why?
|
| Fluoroquinolones | 1 | 2013 | 308 | 0.100 |
Why?
|
| Graft vs Host Disease | 1 | 2023 | 2951 | 0.100 |
Why?
|
| Botulinum Toxins | 1 | 2013 | 192 | 0.100 |
Why?
|
| Hemangioma | 1 | 2016 | 737 | 0.100 |
Why?
|
| Abscess | 2 | 2014 | 607 | 0.090 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2009 | 5171 | 0.090 |
Why?
|
| Mycoses | 1 | 2014 | 376 | 0.090 |
Why?
|
| Paraproteinemias | 1 | 2013 | 247 | 0.090 |
Why?
|
| Ultraviolet Rays | 1 | 2015 | 1059 | 0.090 |
Why?
|
| Inflammation | 4 | 2022 | 10578 | 0.090 |
Why?
|
| Muscle Contraction | 1 | 2015 | 1241 | 0.090 |
Why?
|
| Neoplasm Staging | 2 | 2019 | 11001 | 0.090 |
Why?
|
| In Situ Hybridization | 1 | 2014 | 1950 | 0.090 |
Why?
|
| Lymphocytes | 1 | 2018 | 2614 | 0.090 |
Why?
|
| Mohs Surgery | 1 | 2012 | 197 | 0.090 |
Why?
|
| Breast Neoplasms | 2 | 2017 | 20774 | 0.090 |
Why?
|
| Radiography | 3 | 2015 | 7010 | 0.090 |
Why?
|
| Infarction | 1 | 2011 | 243 | 0.090 |
Why?
|
| Papillomavirus Infections | 1 | 2021 | 1585 | 0.090 |
Why?
|
| Molecular Biology | 1 | 2013 | 595 | 0.090 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2020 | 3502 | 0.080 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2016 | 1675 | 0.080 |
Why?
|
| Gene Rearrangement | 1 | 2014 | 1179 | 0.080 |
Why?
|
| Postoperative Care | 1 | 2015 | 1484 | 0.080 |
Why?
|
| Uterine Neoplasms | 1 | 2017 | 1513 | 0.080 |
Why?
|
| Thyroid Neoplasms | 1 | 2020 | 2274 | 0.070 |
Why?
|
| Lung Neoplasms | 2 | 2009 | 13019 | 0.070 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2017 | 1788 | 0.070 |
Why?
|
| Sinusitis | 1 | 2015 | 922 | 0.070 |
Why?
|
| Neoplasm Proteins | 1 | 2018 | 3691 | 0.070 |
Why?
|
| Viral Load | 1 | 2014 | 3292 | 0.060 |
Why?
|
| Graft Survival | 1 | 2015 | 3733 | 0.060 |
Why?
|
| Self Report | 1 | 2016 | 3548 | 0.060 |
Why?
|
| Meige Syndrome | 1 | 2004 | 12 | 0.060 |
Why?
|
| Reproducibility of Results | 2 | 2023 | 19862 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 1 | 2014 | 6171 | 0.060 |
Why?
|
| Fatal Outcome | 1 | 2009 | 1849 | 0.060 |
Why?
|
| Cyanobacteria | 1 | 2004 | 44 | 0.060 |
Why?
|
| Wound Healing | 1 | 2015 | 2781 | 0.060 |
Why?
|
| Blepharospasm | 1 | 2004 | 30 | 0.060 |
Why?
|
| Amyloidosis | 1 | 2011 | 795 | 0.060 |
Why?
|
| Autoimmune Diseases | 1 | 2015 | 2130 | 0.060 |
Why?
|
| Recurrence | 1 | 2015 | 8333 | 0.060 |
Why?
|
| Immunotherapy | 1 | 2019 | 4414 | 0.060 |
Why?
|
| Infant, Newborn | 3 | 2018 | 25575 | 0.060 |
Why?
|
| Glaucoma | 1 | 2013 | 1152 | 0.060 |
Why?
|
| Antibodies, Viral | 1 | 2014 | 3164 | 0.060 |
Why?
|
| Disease Progression | 1 | 2019 | 13256 | 0.060 |
Why?
|
| Health Status | 1 | 2016 | 4030 | 0.050 |
Why?
|
| Anemia, Sickle Cell | 1 | 2011 | 1017 | 0.050 |
Why?
|
| Neuromuscular Agents | 1 | 2004 | 134 | 0.050 |
Why?
|
| Radiotherapy | 1 | 2009 | 1525 | 0.050 |
Why?
|
| Dermatology | 1 | 2012 | 870 | 0.050 |
Why?
|
| Meibomian Glands | 1 | 2022 | 85 | 0.050 |
Why?
|
| Health Surveys | 1 | 2012 | 4030 | 0.050 |
Why?
|
| Philadelphia | 2 | 1992 | 263 | 0.050 |
Why?
|
| Survival Rate | 1 | 2016 | 12773 | 0.050 |
Why?
|
| Eye Evisceration | 1 | 2021 | 22 | 0.050 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2015 | 1808 | 0.050 |
Why?
|
| Age Factors | 1 | 2019 | 18355 | 0.050 |
Why?
|
| Neoplasm Seeding | 1 | 2001 | 87 | 0.050 |
Why?
|
| Cyclin A | 1 | 2001 | 60 | 0.050 |
Why?
|
| Iopamidol | 1 | 2002 | 191 | 0.050 |
Why?
|
| Botulinum Toxins, Type A | 1 | 2004 | 212 | 0.050 |
Why?
|
| Prognosis | 2 | 2020 | 29010 | 0.050 |
Why?
|
| Brain Neoplasms | 1 | 2001 | 8829 | 0.050 |
Why?
|
| Immunoglobulin A | 1 | 2023 | 992 | 0.050 |
Why?
|
| Prospective Studies | 3 | 2020 | 53187 | 0.040 |
Why?
|
| Pulmonary Alveoli | 1 | 2002 | 675 | 0.040 |
Why?
|
| Referral and Consultation | 1 | 2012 | 3527 | 0.040 |
Why?
|
| Time Factors | 3 | 2016 | 40054 | 0.040 |
Why?
|
| Salivary Glands | 1 | 2020 | 228 | 0.040 |
Why?
|
| Eggs | 1 | 2000 | 184 | 0.040 |
Why?
|
| Bioengineering | 1 | 2019 | 99 | 0.040 |
Why?
|
| Hydrolysis | 1 | 2019 | 682 | 0.040 |
Why?
|
| Scalp | 1 | 2021 | 380 | 0.040 |
Why?
|
| Echo-Planar Imaging | 1 | 2002 | 659 | 0.040 |
Why?
|
| S100 Proteins | 1 | 2018 | 259 | 0.040 |
Why?
|
| T-Lymphocytes | 1 | 2015 | 10163 | 0.040 |
Why?
|
| Vimentin | 1 | 2018 | 261 | 0.040 |
Why?
|
| Thermodynamics | 1 | 1999 | 594 | 0.040 |
Why?
|
| Aneuploidy | 1 | 2001 | 530 | 0.040 |
Why?
|
| Fluoroscopy | 1 | 2002 | 924 | 0.040 |
Why?
|
| Natural Orifice Endoscopic Surgery | 1 | 2019 | 118 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2019 | 23320 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 11472 | 0.040 |
Why?
|
| Iodine Radioisotopes | 1 | 2020 | 1030 | 0.040 |
Why?
|
| Benchmarking | 1 | 2023 | 1038 | 0.040 |
Why?
|
| Neoplasm Metastasis | 2 | 2017 | 4839 | 0.040 |
Why?
|
| Drainage | 2 | 2014 | 1140 | 0.040 |
Why?
|
| Scleritis | 1 | 2017 | 100 | 0.030 |
Why?
|
| Delphi Technique | 1 | 2019 | 778 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1999 | 1723 | 0.030 |
Why?
|
| Craniotomy | 1 | 2000 | 729 | 0.030 |
Why?
|
| Retinal Detachment | 1 | 2019 | 411 | 0.030 |
Why?
|
| Head | 1 | 2021 | 878 | 0.030 |
Why?
|
| Aspergillus | 1 | 2015 | 85 | 0.030 |
Why?
|
| Nasal Septum | 1 | 2016 | 127 | 0.030 |
Why?
|
| Papillomaviridae | 1 | 2021 | 1118 | 0.030 |
Why?
|
| Parotitis | 1 | 2014 | 29 | 0.030 |
Why?
|
| Cell Adhesion Molecules | 1 | 2001 | 1599 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2016 | 772 | 0.030 |
Why?
|
| Crystallography, X-Ray | 1 | 1999 | 2014 | 0.030 |
Why?
|
| Optic Nerve | 1 | 2017 | 548 | 0.030 |
Why?
|
| Hyperbaric Oxygenation | 1 | 2015 | 163 | 0.030 |
Why?
|
| Travel | 1 | 2000 | 788 | 0.030 |
Why?
|
| Cloprostenol | 1 | 2013 | 22 | 0.030 |
Why?
|
| Child, Preschool | 5 | 2016 | 40955 | 0.030 |
Why?
|
| Prostaglandins F, Synthetic | 1 | 2013 | 32 | 0.030 |
Why?
|
| Melanocytes | 1 | 2016 | 515 | 0.030 |
Why?
|
| Meningitis | 1 | 2014 | 216 | 0.030 |
Why?
|
| Pharyngitis | 1 | 2014 | 215 | 0.030 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2016 | 664 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2015 | 40450 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2017 | 1839 | 0.030 |
Why?
|
| Polymers | 1 | 2019 | 1618 | 0.030 |
Why?
|
| Lymphatic Vessels | 1 | 2016 | 351 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2017 | 1905 | 0.030 |
Why?
|
| Ketone Bodies | 1 | 1991 | 81 | 0.030 |
Why?
|
| Prednisone | 1 | 2016 | 1567 | 0.020 |
Why?
|
| Clavulanic Acid | 1 | 2010 | 19 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2014 | 1583 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2004 | 3843 | 0.020 |
Why?
|
| Disease Outbreaks | 1 | 2000 | 1768 | 0.020 |
Why?
|
| Cerebral Angiography | 1 | 2016 | 1285 | 0.020 |
Why?
|
| Pneumonia | 1 | 2002 | 2117 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2016 | 21719 | 0.020 |
Why?
|
| Amides | 1 | 2013 | 458 | 0.020 |
Why?
|
| Carotid Arteries | 1 | 2014 | 952 | 0.020 |
Why?
|
| Prednisolone | 1 | 2011 | 333 | 0.020 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 1991 | 402 | 0.020 |
Why?
|
| Vaccination | 1 | 2022 | 3256 | 0.020 |
Why?
|
| Subcutaneous Fat | 1 | 2013 | 391 | 0.020 |
Why?
|
| Positron-Emission Tomography | 2 | 2017 | 6259 | 0.020 |
Why?
|
| Ocular Motility Disorders | 1 | 2011 | 135 | 0.020 |
Why?
|
| Amoxicillin | 1 | 2010 | 170 | 0.020 |
Why?
|
| Colitis, Ulcerative | 1 | 2001 | 1901 | 0.020 |
Why?
|
| Brachytherapy | 1 | 2017 | 1246 | 0.020 |
Why?
|
| Growth Hormone | 1 | 1991 | 703 | 0.020 |
Why?
|
| Contrast Media | 1 | 2002 | 5295 | 0.020 |
Why?
|
| Reoperation | 1 | 2018 | 4200 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2002 | 8925 | 0.020 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 2010 | 341 | 0.020 |
Why?
|
| Cross-Sectional Studies | 2 | 2022 | 24913 | 0.020 |
Why?
|
| Demography | 1 | 1992 | 1650 | 0.020 |
Why?
|
| Mutation | 2 | 2024 | 29717 | 0.020 |
Why?
|
| DNA | 1 | 2001 | 7289 | 0.020 |
Why?
|
| Proteomics | 1 | 2020 | 3618 | 0.020 |
Why?
|
| Protein Binding | 1 | 1999 | 9387 | 0.020 |
Why?
|
| Embolization, Therapeutic | 1 | 2016 | 1392 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2024 | 9639 | 0.020 |
Why?
|
| Seasons | 1 | 1992 | 1492 | 0.020 |
Why?
|
| Wounds, Nonpenetrating | 1 | 1992 | 794 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 2011 | 2271 | 0.020 |
Why?
|
| Smoking | 1 | 2023 | 8969 | 0.020 |
Why?
|
| Hypothalamus | 1 | 1991 | 1063 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2019 | 8297 | 0.020 |
Why?
|
| Risk Factors | 5 | 2015 | 72145 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2001 | 8425 | 0.020 |
Why?
|
| Severity of Illness Index | 2 | 2019 | 15530 | 0.020 |
Why?
|
| Pain | 1 | 2019 | 4961 | 0.020 |
Why?
|
| Muscle Relaxation | 1 | 2004 | 142 | 0.020 |
Why?
|
| Functional Laterality | 1 | 2011 | 2290 | 0.010 |
Why?
|
| Software | 1 | 2017 | 4434 | 0.010 |
Why?
|
| Diet | 1 | 2000 | 7923 | 0.010 |
Why?
|
| Colorectal Neoplasms | 1 | 2001 | 6754 | 0.010 |
Why?
|
| DNA Fingerprinting | 1 | 2001 | 112 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 18006 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2016 | 13029 | 0.010 |
Why?
|
| Glucose | 1 | 1991 | 4391 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2013 | 12242 | 0.010 |
Why?
|
| Cross-Over Studies | 1 | 2004 | 2030 | 0.010 |
Why?
|
| Phantoms, Imaging | 1 | 2002 | 2466 | 0.010 |
Why?
|
| Animals | 3 | 2020 | 168561 | 0.010 |
Why?
|
| Mice | 1 | 2020 | 81045 | 0.010 |
Why?
|
| Swine | 1 | 2002 | 5934 | 0.010 |
Why?
|
| Nicotinic Acids | 1 | 1991 | 31 | 0.010 |
Why?
|
| Hydroxybutyrates | 1 | 1991 | 83 | 0.010 |
Why?
|
| Oleic Acids | 1 | 1991 | 70 | 0.010 |
Why?
|
| Injections, Intraventricular | 1 | 1991 | 230 | 0.010 |
Why?
|
| Image Enhancement | 1 | 2002 | 2921 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2004 | 12017 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2001 | 15056 | 0.000 |
Why?
|
| Macaca mulatta | 1 | 1991 | 2378 | 0.000 |
Why?
|
| Hydrocortisone | 1 | 1991 | 1825 | 0.000 |
Why?
|
| Insulin | 1 | 1991 | 6575 | 0.000 |
Why?
|